Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Liver Diseases × Lead × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 3 Brain Neoplasms 2 Thrombophilia 1 Stomach Neoplasms 1 Prostatic Neoplasms 1 Neoplasms 1 Motor Activity 1 Liver Neoplasms 1 Liver Diseases 1 Central Nervous System Neoplasms 1 Blood Coagulation Disorders 1

Interventions

toripalimab 1 tislelizumab 1 sintilimab 1 pembrolizumab 1 lenvatinib 1 gadolinium ethoxybenzyl DTPA 1 camrelizumab 1 User-Centered Design 1 Nivolumab 1 Neuropsychological Tests 1 Lead 1 Blood Specimen Collection 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05931068 2024-08-05

PRO-NRG

Academisch Ziekenhuis Maastricht

Gastrointestinal

Liver Diseases, Liver Neoplasms, Motor Activity, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡